Nav: Home

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021

February 08, 2018

Hematology is a branch of medicine, which deals with the study of blood, blood-forming organs, and blood diseases. Hematology includes problems related with white blood cells, red blood cells, bone marrow, lymph, and platelets. It also affects the liquid component of blood known as plasma. Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology. A specialist in hematology treatment is known as hematologist. Bleeding disorders such as hemophila and blood clots, and blood cancer are some types of blood conditions. Some of the blood-associated diseases are anemia, leukemia, myelofibrosis, blood transfusion, malignant lymphomas, and bone marrow stem cell transplantation. Hematology is diagnosed through hematology tests.

Hematology diagnoses anemia, infection, hemophilia, and blood clotting. Anemia is caused by various reasons such as iron deficiency, vitamin B-12 deficiency, chronic lead poisoning, and red blood cell destruction. Anemia is prominent in women. Hemophilia is an inherited blood disorder, in which, blood does not clot properly. Blood clots are clumps formed when blood hardens from liquid to solid. Blood tests include complete blood count, blood enzyme test, platelet count, international normalized ratio, and lipoprotein panel. Fatigue, pale skin, and shortness of breath with exertion are some of the common symptoms of blood disorder. Hemostatis, hematology reagents, immunohematology, and hematology rapid tests are some of the hematology diagnostics systems. Hemostatis is the largest segment of the global hematology diagnostics market.

Request to sample report @ https://www.persistencemarketresearch.com/samples/3876

North America, followed by Europe, dominates the global hematology market due to the availability of a large number of diagnostic centers . Rising R&D investments is also fueling growth of the North America hematology diagnostics market. Asia is expected to witness a high growth rate due to improving healthcare infrastructure . China and India in emerging countries are expected to witness fast growth due to the availability of large patient pools. In addition, rising demand for technologically-advanced diagnosis devices and increased purchasing power of consumers are driving growth of the Asia hematology diagnostics market.

In recent years, the use of hematology diagnostics has increased due to increasing incidences of blood disorder diseases. Increasing aging population, technological advancements, and rising demand for improved healthcare facilities are some of the key factors driving growth of the global hematology diagnostics market. In addition, rising government initiatives to support healthcare infrastructure is also fueling growth of the global hematology diagnostics market. However, high cost of diagnostics and poor healthcare insurance coverage for diagnostic procedures are some of the key factors restraining growth of the global hematology diagnostics market. In addition, lack of awareness among people regarding haematology diagnostics is also restraining growth of the global hematology diagnostics market.

The market for hematology diagnostic devices is expected to increase due to rising support from various private and government organizations. Introduction of digital imaging systems in hematology laboratories and growing use of microfluidics technology in hematology analyzers could create opportunities for growth of the global hematology diagnostics market. Some of the companies operating in the global hematology diagnostics market are Abbott Laboratories, Hemocue, Horiba, Siemens Healthcare diagnostics, and Beckman Coulter. Other companies include Bio-Rad Laboratories, Nihon Kohden Corporation, and Roche Diagnostics.
-end-
Request Report for TOC @ https://www.persistencemarketresearch.com/toc/3876

Key features of this report

Drivers, restraints, and challenges shaping the Hematology Diagnostics market dynamics

Latest innovations and key events in the industry

Analysis of business strategies of the top players

Hematology Diagnostics market estimates and forecasts(2015 -2021)

Health Affairs

Related Bone Marrow Articles:

Viagra shows promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem cells for bone marrow transplants using a combination of Viagra and a second drug called Plerixafor.
Bone marrow may be the missing piece of the fertility puzzle
A woman's bone marrow may determine her ability to start and sustain a pregnancy, report Yale researchers in PLOS Biology.
Cells that make bone marrow also travel to the womb to help pregnancy
Bone marrow-derived cells play a role in changes to the mouse uterus before and during pregnancy, enabling implantation of the embryo and reducing pregnancy loss, according to research published Sept.
Uncovering secrets of bone marrow cells and how they differentiate
Researchers mapped distinct bone marrow niche populations and their differentiation paths for the bone marrow factory that starts from mesenchymal stromal cells and ends with three types of cells -- fat cells, bone-making cells and cartilage-making cells.
Zebrafish help researchers explore alternatives to bone marrow donation
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need for bone marrow donation.
New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.
Blood diseases cured with bone marrow transplant
Doubling the low amount of total body radiation delivered to patients undergoing bone marrow transplants with donor cells that are only 'half-matched' increased the rate of engraftment from only about 50 percent to nearly 100 percent, according to a new study by Johns Hopkins researchers.
Vitamin D and immune cells stimulate bone marrow disease
The bone marrow disease myelofibrosis is stimulated by excessive signaling from vitamin D and immune cells known as macrophages, reveals a Japanese research team.
Malignant bone marrow disease: New hope for MPN patients
Myeloproliferative neoplasms (MPNs) are still difficult to treat. A team from Vetmeduni Vienna and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences/Medical University of Vienna has discovered a new therapeutic approach that could fundamentally change this situation, as evidenced by a study that was published recently in the academic journal Blood.
Scientists have identified a bone marrow backup system
New research from the Stowers Institute for Medical Research has identified a backup for an important biological system -- the hematopoietic system, whose adult stem cells constantly replenish the body's blood supply.
More Bone Marrow News and Bone Marrow Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab